Robert Wilson
Président chez CALCIMEDICA, INC.
Fortune : 1 M $ au 30/04/2024
Profil
Robert N.
Wilson is currently the Chairman at CalciMedica, Inc. (US) since 2020 and at CalciMedica, Inc. since 2023.
Previously, he served as the Vice Chairman at Johnson & Johnson from 1964 to 2003.
He was also the Chairman at VIVUS, Inc. in 2013 and 2014, and at Caxton Health Holdings LLC in 2007.
Additionally, he held the position of Chairman at Mevion Medical Systems, Inc. from 2005 to 2016.
Mr. Wilson served as an Independent Director at The Charles Schwab Corp.
from 2003 to 2019 and at Synta Pharmaceuticals Corp.
from 2003 to 2016.
He was an Independent Director at Hess Corp.
from 1991 to 2016.
Mr. Wilson's education includes undergraduate degrees from The Trustees of Columbia University in The City of New York and Georgetown College.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
CALCIMEDICA, INC.
2,33% | 31/03/2024 | 250 475 ( 2,33% ) | 1 M $ | 30/04/2024 |
Postes actifs de Robert Wilson
| Sociétés | Poste | Début |
|---|---|---|
| CALCIMEDICA, INC. | Président | 20/03/2023 |
CalciMedica, Inc. (US)
 CalciMedica, Inc. (US) BiotechnologyHealth Technology CalciMedica, Inc. is a holding company, which engages in drug development. It discovers and develops novel small molecule drugs for the treatment of inflammatory and autoimmune disorders and organ transplant rejection. The company was founded by Gonul Velicelebi, Kenneth Stauderman, Anjana Rao, Patrick Hogan, Stefan Feske, Michael Harpold, Tom Reed, and Jack Roos in December 2006 and is headquartered in La Jolla, CA. | Président | 02/06/2020 |
Anciens postes connus de Robert Wilson
| Sociétés | Poste | Fin |
|---|---|---|
| CHARLES SCHWAB | Directeur/Membre du Conseil | 15/01/2019 |
Synta Pharmaceuticals Corp.
 Synta Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Synta Pharmaceuticals Corp. discovers, develops and commercializes pharmaceutical products. It focuses on the research, development and commercialization of oncology medicines that provides treatment to cancer patients. The company is also developing a proprietary platform for delivery of anti-cancer drugs directly to tumor cells, known as Hsp90-inhibitor drug conjugates. Synta Pharmaceuticals was founded by Safi R. Bahcall and Lan-Bo Chen in March 2000 and is headquartered in Lexington, MA. | Directeur/Membre du Conseil | 22/07/2016 |
| HESS CORPORATION | Directeur/Membre du Conseil | 04/05/2016 |
Mevion Medical Systems, Inc.
 Mevion Medical Systems, Inc. Medical SpecialtiesHealth Technology Mevion Medical Systems, Inc. provides proton therapy systems for cancer centers, clinicians and patients worldwide. Its MEVION S250 Series is designed to deliver proton therapy treatments, optimizing both the outcomes and the economics of proton therapy. Its products include Mevion S250i with hyperscan and Mevion 250mx. The company was founded by Kenneth A. Gall in 2004 and is headquartered in Littleton, MA. | Président | 01/01/2016 |
| VIVUS, INC. | Président | 20/06/2014 |
Formation de Robert Wilson
| Georgetown College | Undergraduate Degree |
| The Trustees of Columbia University in The City of New York | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| CHARLES SCHWAB | Finance |
| HESS CORPORATION | Energy Minerals |
| JOHNSON & JOHNSON | Health Technology |
| Entreprise privées | 9 |
|---|---|
Synta Pharmaceuticals Corp.
Synta Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Synta Pharmaceuticals Corp. discovers, develops and commercializes pharmaceutical products. It focuses on the research, development and commercialization of oncology medicines that provides treatment to cancer patients. The company is also developing a proprietary platform for delivery of anti-cancer drugs directly to tumor cells, known as Hsp90-inhibitor drug conjugates. Synta Pharmaceuticals was founded by Safi R. Bahcall and Lan-Bo Chen in March 2000 and is headquartered in Lexington, MA. | Health Technology |
US Trust Corp.
 US Trust Corp. Regional BanksFinance US Trust Corp. provides integrated wealth management solutions. It offers solutions that leverage the company's expertise in investment management, planning services, private banking and trust services. The company was founded by John Aikman Stewart in 1853 and is located in New York City, NY. | Finance |
Mevion Medical Systems, Inc.
Mevion Medical Systems, Inc. Medical SpecialtiesHealth Technology Mevion Medical Systems, Inc. provides proton therapy systems for cancer centers, clinicians and patients worldwide. Its MEVION S250 Series is designed to deliver proton therapy treatments, optimizing both the outcomes and the economics of proton therapy. Its products include Mevion S250i with hyperscan and Mevion 250mx. The company was founded by Kenneth A. Gall in 2004 and is headquartered in Littleton, MA. | Health Technology |
United States Trust Co., NA
 United States Trust Co., NA Major BanksFinance On April 12, 1853, the New York State legislature passed a bill chartering the United States Trust Co. of New York with the mission of serving as manager, executor and trustee of personal and corporate funds. They opened for business in New York City in August of that year. US Trust has divisions in Connecticut, New York, New Jersey, Pennsylvania, North Carolina, Florida, Texas, Oregon, California, Washington, and the District of Columbia. The firm also owns Campbell Cowperthwait, which manages growth-oriented portfolios for U.S. Trust's institutional clients. | Finance |
Caxton Health Holdings LLC
 Caxton Health Holdings LLC Financial ConglomeratesFinance Caxton Health Holdings LLC operates as an investment firm. It focus on healthcare sectors, such as healthcare technologies, biopharmaceuticals, drug discovery technology and healthcare information technology. The company is headquartered in New York, NY. | Finance |
VIVUS, Inc.
 VIVUS, Inc. Pharmaceuticals: MajorHealth Technology VIVUS, Inc. engaged in the development and commercialization of novel therapeutic products. The firm’s products were indicated for the treatment of obese and overweight patients, exocrine pancreatic insufficiency, and erectile dysfunction. Its products include PANCREAZE, Qsymia, and STENDRA/SPEDRA. The company was founded by Virgil A. Place in April 16, 1991 and it was headquartered in Campbell, CA. | Health Technology |
CalciMedica, Inc. (US)
CalciMedica, Inc. (US) BiotechnologyHealth Technology CalciMedica, Inc. is a holding company, which engages in drug development. It discovers and develops novel small molecule drugs for the treatment of inflammatory and autoimmune disorders and organ transplant rejection. The company was founded by Gonul Velicelebi, Kenneth Stauderman, Anjana Rao, Patrick Hogan, Stefan Feske, Michael Harpold, Tom Reed, and Jack Roos in December 2006 and is headquartered in La Jolla, CA. | Health Technology |
| CalciMedica, Inc. | |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Health Technology |
